Number of the records: 1  

Hetero-Bis-Conjugation of Bioactive Molecules to Half-Sandwich Ruthenium(II) and Iridium(III) Complexes Provides Synergic Effects in Cancer Cell Cytotoxicity

  1. 1.
    SYSNO ASEP0554906
    Document TypeJ - Journal Article
    R&D Document TypeJournal Article
    Subsidiary JČlánek ve WOS
    TitleHetero-Bis-Conjugation of Bioactive Molecules to Half-Sandwich Ruthenium(II) and Iridium(III) Complexes Provides Synergic Effects in Cancer Cell Cytotoxicity
    Author(s) Biancalana, L. (IT)
    Kostrhunová, Hana (BFU-R) RID, ORCID
    Batchelor, L. (CH)
    Hadiji, M. (CH)
    Degano, I. (IT)
    Pampaloni, G. (IT)
    Zacchini, S. (IT)
    Dyson, P.J. (CH)
    Brabec, Viktor (BFU-R) RID, ORCID
    Marchetti, F. (IT)
    Number of authors10
    Source TitleInorganic Chemistry. - : American Chemical Society - ISSN 0020-1669
    Roč. 60, č. 13 (2021), s. 9529-9541
    Number of pages13 s.
    Publication formPrint - P
    Languageeng - English
    CountryUS - United States
    Keywordsanticancer agents ; platinum(iv) prodrug ; crystal-structure ; rational design ; acid ; derivatives
    OECD categoryOrganic chemistry
    R&D ProjectsGC20-14082J GA ČR - Czech Science Foundation (CSF)
    Method of publishingLimited access
    Institutional supportBFU-R - RVO:68081707
    UT WOS000671099600035
    EID SCOPUS85110193018
    DOI10.1021/acs.inorgchem.1c00641
    AnnotationFour bipyridine-type ligands variably derivatized with two bioactive groups (taken from ethacrynic acid, flurbiprofen, biotin, and benzylpenicillin) were prepared via sequential esterification steps from commercial 2,2'-bipyridine-4,4'-dicarboxylic acid and subsequently coordinated to ruthenium(II) p-cymene and iridium(III) pentamethylcyclopentadienyl scaffolds. The resulting complexes were isolated as nitrate salts in high yields and fully characterized by analytical and spectroscopic methods. NMR and MS studies in aqueous solution and in cell culture medium highlighted a substantial stability of ligand coordination and a slow release of the bioactive fragments in the latter case. The complexes were assessed for their antiproliferative activity on four cancer cell lines, showing cytotoxicity to the low micromolar level (equipotent with cisplatin). Additional biological experiments revealed a multimodal mechanism of action of the investigated compounds, involving DNA metalation and enzyme inhibition. Synergic effects provided by specific combinations of metal and bioactive fragments were identified, pointing toward an optimal ethacrynic acid/flurbiprofen combination for both Ru(II) and Ir(III) complexes.
    WorkplaceInstitute of Biophysics
    ContactJana Poláková, polakova@ibp.cz, Tel.: 541 517 244
    Year of Publishing2022
    Electronic addresshttps://pubs.acs.org/doi/10.1021/acs.inorgchem.1c00641
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.